Leerink Partnrs Issues Negative Outlook for Merus Earnings
Merus (NASDAQ:MRUS – Free Report) – Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Merus in a report released on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will post earnings of ($1.28) per share for the quarter, down from their prior […]
Merus (NASDAQ:MRUS – Free Report) – Research analysts at Leerink Partnrs cut their Q1 2025 earnings per share (EPS) estimates for Merus in a report released on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will post earnings of ($1.28) per share for the quarter, down from their prior […]
